chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I've had a rash on the same arm as the shot.  It has appeared over the last two months.  It can be there for days or weeks.   No medical treatment, going to doctor next week.
Developer rash at injection sites; small itch and rash/ small bumps develop on her face and arms/ itchy/ diagnosed with pityriasis rosea; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in arm left on 29Apr2021 17:00 (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. Medical history included known penicillin allergies. No other medical history. The patient previously received first dose of BNT162B2 in left arm on 07Apr2021 17:00 PM. The patient was not pregnant. No other vaccine in four weeks and other medications in two weeks. The patient's concomitant medications were not reported. Developer rash at injection sites on 20May2021 20:00. First started as small itch and rash that wouldn't go away. Almost 3 weeks after getting the final shot (around 20May2021), she saw small bumps develop on her face and arms. The rash at the injection site also seemed to spread. Took antihistamines (24May2021) but would not go away. She went to first doctor and they gave her antibiotics (doxycycline on 25May2021). Did not like the effects that it had on her body so she went to another doctor who gave her steroids (26May2021) Took that for 6 days and bumps on face got considerably worse. They were always itchy but never hurt or looked pus filled. She went to another doctor who gave her a fungal cream (02Jun2021) to put on them and also a recommendation to the dermatologist. She went to dermatologist (04Jun2021) and they diagnosed with pityriasis rosea and gave her acyclovir. This rash was only on her face and along her shoulders where she got the vaccines to her forearms. Still very itchy at the moment. The patient underwent lab tests included COVID-19 Nasal Swab PCR test negative on 25May2021. The event resulted in: Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Treatment included 1-doxycycline,2-steroids,3- ketoconazol,4-acyclovir and Anti-histamine. No covid prior vaccination. The outcome of events was recovering. Seriousness was reported as non-serious as not resulted in death, life threatening, caused or prolonged hospitalization, disabling or incapacitating or congenital anomaly or birth defect.  Information about lot/batch number has been requested.
optic nerve inflamed, causing vision obstructed; Optic ischemic neuropathy; Vission still distorted; loss of vision, center field of vision; This case was reported by a consumer via call center representative and described the occurrence of loss of vision in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 1st September 2022, 3 days after receiving Shingrix, the patient experienced loss of vision (serious criteria GSK medically significant). On an unknown date, the patient experienced optic neuritis (serious criteria GSK medically significant), ischemic optic neuropathy (serious criteria GSK medically significant) and distorted vision. The patient was treated with prednisone. On an unknown date, the outcome of the loss of vision was recovering/resolving and the outcome of the optic neuritis and ischemic optic neuropathy were unknown and the outcome of the distorted vision was not recovered/not resolved.   It was unknown if the reporter considered the loss of vision, optic neuritis, ischemic optic neuropathy and distorted vision to be related to Shingrix.     Additional Information: GSK Receipt date: 16-Feb-2023. Reporter's Comment: The patient self-reported this case. Patient received Shingrix on left deltoid and 3 to 5 days later he started losing vision in his left eye in the center field of vision. The patient went to his eye doctor, specialist in retina care, who reported the optic nerve was inflamed causing the vision to be obstructed but not sure why.  The eye doctor ordered 3 magnetic resonance imaging and bloodwork.  The eye specialist though he could have multiple sclerosis, but the bloodwork did not confirm this. The eye specialist sent him to another eye specialist who started him on large doses of Prednisone.  On the return visit to the second eye specialist, he happens to mention he received the Shingrix vaccine.  At that point, the specialist saw where there had been 3 cases of optic ischemic neuropathy reported in the Shingrix package insert.  The eye specialist at that point thought the Shingrix vaccine had caused this.  The reporter reported his vision has gotten better, but it was still distorted. The reporter gives permission to contact the all the doctor's in this case. The reporter consented to follow-up. Additional Supportive Information: The case was linked with case US2023AMR027483, US2023AMR027496 and US2023AMR027497, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR027483:Same reporter US-GSK-US2023AMR027496:Same reporter US-GSK-US2023AMR027497:Same reporter
So 12/05/2022 at around 5PM I started to feel slightly feverish and my eyes were tingling and my head felt congested. I had no pain and no other symptom at that time. The next day I started to develop more congestion nasal and a runny nose my fever was increasing, my temperature was 102 degrees and I started to develop a dry cough. On the third day I was miserable my head was fully congested as those I had head cold and I had trouble breathing through my nose my head and chest felt fine but I called my doctor because I could not work my doctor had me alternate between ADVIL and TYLENOL for fever and use FLONASE and a saline solution for my nose, if necessary take MUCINEX DM to suppress cough and allow me to sleep. On the fourth day I was not feeling better so on my own I began to take SUDAFED for my congestion and this helped a lot and my fever was down by the fourth day by the fifth day my fever broke and I alternated ADVIL, TYLENOL, SUDAFED, FLONASE. No chest pain in the chest or lungs were present during the illness but ears would pop throughout the illness as when going to higher altitudes especially at night. For fourteen days I continued the regimen and tested negative for COVID-19.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. Medical history and concomitant medications were not provided. On 17-NOV-2016, the patient received one expired dose of PNEUMOVAX 23 (lot number L021356; expiration 05-NOV-2016). No adverse effect was reported. Additional information has been requested.
Janssen COVID-19 Vaccine EUA  .....    side effects I experienced beginning several hours after vaccine, with some lasting until 72 hours later:  chills/body shakes, 101 degree fever, headache, body aches, fatigue, sore left arm, nausea.
Local severe reaction 120 mm local erythema and induration with painful axillary nodes, malaise. Afebrile, Headaches resolved, no breathing difficulty or angioedema.
woke with nausea and vomiting day after vaccine administered, also with dizziness, chills, and loose/urgent stools. pt declined prescription anti-nausea medication, recommended hydration and otc anti-nausea meds as needed and to monitor symptoms a this time
*Injection to (L) upper shoulder 1 1/2" gauge 23 Needle - Injected into (L) subacromial space Not Deltoid Muscle *Reaction Pain with overhead ROM, Internal rotation, external rotation abduction + adduction. -Worsened as day increased *Treated steroids 60mg x 2d, 40mg, 20mgx2day 10mg x 2d. -Ibuprofen 800mg PO TID, Ice. Placed light duty. Dr. had employee nurse from his clinic give her influenza injection to her left arm around 1:30PM on 9/15/2020. She started to Employee stated pain started as soon as she had the shot, worsened as the day progressed. She was injected around 1:30PM and by the time she is driving home around 5pm it was painful to internally rotate the steering wheel of her car. She completed some ROM at home and decided to start some steroids, this did help her pain along with ibuprofen. She took 60 MG of steroids. Last PM, she does not have any more steroids. This provider is able to visualize pin size injection site high on left shoulder, directed toward subacromial space of left shoulder. Pain and weakness (Pain left shoulder joint, exacerbated by overhead activities).
Seizure - 03:00 am - and was taken by ambulance to Hospital - there I had MRI on brain, CT scan and EEG; they did not release me on any kind of meds. They told me to follow up with my doctor. I was at the hospital until the afternoon of the 5th. I went to see the doctor on 19th of August. I showed him the test Disks - a dozen Flashes on brain on MRI- he said they were mini-strokes. He ordered an EEG - repeat. That was done on August 26th. On Sept 11, I was taken by ambulance again to the same hospital at 03:00 am again for seizure - they didn't admit me but kept me in ER - released at 09:00 am. They released me on 500 mg of Keppra. I am still having the seizure issues - last night, my husband said that I had several last night and one lasted about 10 minutes ( I don't remember it). The seizures can last just a moment or so. I had some yesterday - tingling in my arm and then I can feel a warmth running up my chest and into my mouth I have a weird metallic taste - that I was conscious of during the day. On Sept 20th- my looked at that and everything was fine. I started me on Dilantin 100 mg - two at bedtime and Simvastatin - 20 mg once in the morning. - instead of staying on the  Keppra. I don't drink alcohol. November 18th - Doctor will do a repeat EEG. History: I have had bells palsy - but that was 25 years ago and shingles about 5 years ago. But I have never had any seizures before.
fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 02Sep2021 at 15:00 as dose 1, single (Batch/Lot number: unknown) at the age of 70 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension", start date: 1984 (ongoing); "High cholesterol", start date: 1984 (ongoing); "Thrombophlebitis with Pulmonary Embolism", start date: 1972 (unspecified if ongoing), notes: Thrombophlebitis with Pulmonary Embolism; "Thrombophlebitis with Pulmonary Embolism", start date: 1972 (unspecified if ongoing), notes: Thrombophlebitis with Pulmonary Embolism. The patient's family history included: "Fibromyalgia", start date: 1984 (ongoing); "Diabetes" (ongoing); "Heart disease" (ongoing). There were no concomitant medications. The following information was reported: FATIGUE (non-serious), outcome "unknown".  Additional information: The patient did not receive any prior vaccination. There were no relevant test and specific relevant test for thromboembolic events with thrombocytopenia.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
My chronic hives were relatively calm prior to the vaccine. The next day they became severe and were severe for several days before calming down.
This spontaneous reprot as received from a Medical Assistant refers to a multiple patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the patients was vaccinated with oral, ROTATEQ lot # K010224, expiration date 13-MAY-2016 (dose was not reported). The patients received a dose of oral, ROTATEQ that was stored improperly. There was no adverse effects reported. Additional information has been requested.
Patient developed pruritic rash on her legs five hours after receiving the moderna vaccine.  Patient was seen by physician and given topical steroid and OTC antihistamine for symptom relief.
This spontaneous report as received from a medical assistant refers to 3 patients of unknown age. The 3 patients were vaccinated with PNEUMOVAX 23 (lot number reported as H010661, expiration date 02-FEB-2014) intramuscularly. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the 3 patients developed a fever, redness, and swelling around the injection site as well as "around the arm" after receiving PNEUMOVAX 23. TYLENOL, dexamethasone, cold compresses were given for adverse event as treatment. The outcome of adverse events was reported as recovering/resolving. No laboratory diagnostics studies were performed. The 3 patients had sought unspecified medical attention. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Patient reported being 12 years old and uninsured and received 1 dose of Pfizer at age of 11.
raised, red rash bilateral hands from inside of thumbs to mid-forarm.  provided 50mg of diphenhydramine.  observed patient for additional 30 minutes.  rash decreased in severity and there were no other symptoms (difficulty breathing, increased heart rate, etc)
I experienced axillary lymph node swelling from my axilla down to my wrist with associated numbness and tingling approximately 3-5 days post shot and went to see my health care provider on 2/3/2021.
Erythematous wheal 2 cm x 3 cm coalesced with a 2 cm wheal on (R) upper lateral arm over deltoid. A 4 cm wheal inferior and medial to the above. White rim, warm to touch, blanching.
SHINGLES (HERPES ZOSTER) - JULY 13, 2020  PAIN, ITCHING, BLISTERS  PRESCRIBED VALTREX 1 gram tablet BID - ONE PILL 3 TIMES A DAY FOR 7 DAY  BASICALLY CLEARED IN 3 weeks with one remaining blister  SHINGRIX - DOSE 1 - 10/22/18 LEFT ARM  DOSE 2 - 1/28/19 LEFT ARM  VARICELLA (HERPES ZOSTER) ZOSTAVAX  2011
Lesions of varying stages widespread. Dx: Chicken pox post vaccination. Tx: symptomatic.
swelling to left upper arm. after swelling resolved, muscle cramps to left upper arm. pain in left upper arm that radiates to lower arm and hand. pain is intermittent, lasts 2 hours, self- resolves or resolves with massage. pain waxes and wanes. no paresthesias, retains full range of motion to arm and hand
fever blisters, they're quite big / I must have herpes duplex; This case was reported by a consumer via call center representative and described the occurrence of fever blister in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2022, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced fever blister. On an unknown date, the outcome of the fever blister was not recovered/not resolved.   It was unknown if the reporter considered the fever blister to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received a second Shingrix shot a week ago (from the day of reporting) and experienced two fever blisters. The reporter inquired that whether that was a common occurrence or just coincidence. The reporter stated about reading all the possible side effects on the website before contacting and did not believe that they ever had two fever blisters at the same time before and were quite big. The reporter mistakenly thought the zoster virus and herpes simplex were related and must have herpes duplex.
Swollen lymphnode right above my collarbone on the left side. Noticed (to the touch) on 2/20/21, 9 days after my shot. It is still swollen.
Extreme joint and muscle pain that is progressively getting worse since the first injection received third booster shot March 4th 2022 and joint pain is still increasingly getting worse
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: pt did not report history of syncope after vaccination. only told me after event occured. pt said he felt dizzy and sat back down in the post-vaccination area chair. monitored for approximately 40 minutes and pt's appeared to be stable and mobile alert and oriented and asked to go home. followed up with patient at 4 pm and he reported that he was feeling much better and appreciated us reaching out to him
Mother died; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (Mother died) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant medications were not provided. No Treatment information was reported.   Reporter wanted information on how many people had to die before they stop giving these injections, reporter's mother had died.  Company comment: This spontaneous case concerns a female patient of unspecified age with no medical history reported, who experienced the fatal unexpected serious event of death that occurred unknown days after receiving a dose of mRNA-1273 vaccine in covid-19 vaccination series. Latency cannot be assessed as vaccination dates and event onset dates were not provided. No further details on risk factors, clinical course, patient's medical history and additional vaccination details were reported. Date of death and cause of death was unknown. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Events' seriousness was assessed as per medical judgement and available information.   The reporter stated that vaccine was full of toxins and stated there was no data on effectiveness.   This case was linked to US-MODERNATX, INC.-MOD-2022-639298, US-MODERNATX, INC.-MOD-2022-639300, US-MODERNATX, INC.-MOD-2022-639297 (E2B Linked Report).; Sender's Comments: This spontaneous case concerns a female patient of unspecified age with no medical history reported, who experienced the fatal unexpected serious event of death that occurred unknown days after receiving a dose of mRNA-1273 vaccine in covid-19 vaccination series. Latency cannot be assessed as vaccination dates and event onset dates were not provided. No further details on risk factors, clinical course, patient's medical history and additional vaccination details were reported. Date of death and cause of death was unknown. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Events' seriousness was assessed as per medical judgement and available information. US-MODERNATX, INC.-MOD-2022-639300:16 of her Friend's case/ people all over the world US-MODERNATX, INC.-MOD-2022-639298:Brother in law case US-MODERNATX, INC.-MOD-2022-639297:Father in law case; Reported Cause(s) of Death: Unknown cause of death
Tiredness; headache; muscle pain; chills; joint pain; fever; nausea; feeling unwell; vomiting; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported) via an unknown route of administration on 03Mar2021 at 13:15 pm as 1ST DOSE, SINGLE for covid-19 immunization. Medical history included none and Concomitant medications in two weeks included Dabigatran etexilate mesilate (PRADAXA).  prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Mar2021 at 08:00 am, the patient experienced tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell and vomiting. No treatment was received for the events. The outcome of the events was not resolved.   No follow-up attempts were possible; information about lot/batch number cannot be obtained.
Severe, watery diarrhea; This is a spontaneous report from a non-contactable other healthcare professional. A 30-year-old female patient received bnt162b2 (BNT162B2, lot no and expiry date was unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient is not pregnant. The patient experienced severe, watery diarrhea on 18Dec2020. No treatment received for the event. The outcome of the event was not recovered.   No follow-up attempts are possible, information about batch number cannot be obtained.
Rash on torso and back: currently ongoing for 36 hours since a few hours after vaccine
Patient seen for knee pain, chest pressure and chronic fatigue. She eventually went to the emergency room.
vial that was at room temperature since  the 23Nov2021.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Nov-2021 and was forwarded to Moderna on 27-Nov-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (vial that was at room temperature since  the 23Nov2021.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (vial that was at room temperature since  the 23Nov2021.). On 26-Nov-2021, PRODUCT STORAGE ERROR (vial that was at room temperature since  the 23Nov2021.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported
Information has been received from a certified medical assistant concerning a 57 year old female with unknown allergies who on 07-AUG-2008 was vaccinated with PNEUMOVAX (lot # 655501/1035F). On 12-AUG 2008, the patient returned to the physician's office with injection site redness which was sized at half of her upper arm, injection site swelling and warm to touch. The patient also had a fever. The medical assistant reported that MEDROL DOSEPAK and antibiotic (unspecified) was ordered for the patient. The patient was also sent for chest x-ray, results were not back as yet. At the time of reporting, the patient had not recovered from injection site redness, injection site swelling and warm to touch and fever. Additional information has been requested.
Headache, Sedation, Arthralgia, Fever, NauseaVomiting, chills and fatigue, pain, swelling and infection at the injection site Narrative:  On the day of the vaccination, patient developed pain and swelling at the injection site and also a headache that lasted approx~36 hours. The next day patient developed chills, fever, arthralgia, fatigue, tiredness and nausea. Patient saw her PCP and was diagnosed with cellulitis and is currently on her 2nd antibiotic to treat it. All symptoms except infection, swelling, pain and redness have resolved.
Moderna COVID?19 Vaccine EUA. After second dose on 06/04/21, the pharmacist stated that the manufacturer sent different needles that were 3 inches, needle went in too far, my right arm was sore for two weeks, then my right shoulder started hurting more, to where it hurts to lift at times.
About 3-4 days after injection I developed tinnitus in my right ear. I had minor tinnitus in my left ear very once in a while but after the vaccine shot I have developed constant tinnitus in my right ear that has not gone away.